We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
34 hedge funds and large institutions have $187M invested in Enzymotec Ltd in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
367% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 3
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
72% more capital invested
Capital invested by funds: $109M → $187M (+$78.5M)
48% more funds holding
Funds holding: 23 → 34 (+11)
Holders
34
Holders Change
+11
Holders Change %
+47.83%
% of All Funds
0.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
12
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PC
Paulson & Co
New York
|
+$67.3M |
| 2 |
VAM
Visium Asset Management
New York
|
+$11.9M |
| 3 |
Millennium Management
New York
|
+$9.86M |
| 4 |
AP
Alydar Partners
Boston,
Massachusetts
|
+$5.87M |
| 5 |
PA
Perceptive Advisors
New York
|
+$5.68M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14M |
| 2 |
Goldman Sachs
New York
|
-$351K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$327K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$270K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$185K |
